ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $466,000 | -19.0% | 39,629 | -5.8% | 0.00% | -100.0% |
Q1 2019 | $575,000 | +49.7% | 42,081 | +12.0% | 0.00% | – |
Q4 2018 | $384,000 | +4.1% | 37,575 | +69.9% | 0.00% | – |
Q3 2018 | $369,000 | +5.7% | 22,110 | 0.0% | 0.00% | – |
Q2 2018 | $349,000 | +24.2% | 22,110 | 0.0% | 0.00% | – |
Q1 2018 | $281,000 | +11.1% | 22,110 | 0.0% | 0.00% | – |
Q4 2017 | $253,000 | -6.6% | 22,110 | 0.0% | 0.00% | – |
Q3 2017 | $271,000 | +8.4% | 22,110 | +6.2% | 0.00% | – |
Q2 2017 | $250,000 | -43.3% | 20,810 | -1.4% | 0.00% | – |
Q1 2017 | $441,000 | -38.0% | 21,100 | -38.2% | 0.00% | -100.0% |
Q4 2016 | $711,000 | -68.9% | 34,161 | -51.7% | 0.00% | -50.0% |
Q3 2016 | $2,288,000 | +52.3% | 70,698 | +17.5% | 0.00% | 0.0% |
Q2 2016 | $1,502,000 | +205.3% | 60,167 | +199.2% | 0.00% | +100.0% |
Q1 2016 | $492,000 | -23.6% | 20,112 | +5.5% | 0.00% | 0.0% |
Q4 2015 | $644,000 | +3.0% | 19,070 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $625,000 | -47.7% | 19,070 | -15.5% | 0.00% | 0.0% |
Q2 2015 | $1,196,000 | – | 22,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |